Repurposing cAMP-modulating medications to promote β-cell replication

Molecular Endocrinology

Volumn 28, Issue 10, 2014, Pages 1682-1697

  Zhao, Zhenshan ^a   Low, Yen S ^a   Armstrong, Neali A ^a   Ryu, Jennifer Hyoje ^b   Sun, Sara A ^a   Arvanites, Anthony C ^b   Hollister Lock, Jennifer ^c   Shah, Nigam H ^d   Weir, Gordon C ^c   Annes, Justin P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Harvard University   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CILOSTAMIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPYRIDAMOLE; ETAZOLATE; GLAUCINE; GLUCOSE; IRSOGLADINE MALEATE; ISOBUTYLMETHYLXANTHINE; MILRINONE; MIRTAZAPINE; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE X INHIBITOR; ROLIPRAM; TADALAFIL; TREQUINSIN; UNCLASSIFIED DRUG; VARDENAFIL; VOLTAGE GATED CALCIUM CHANNEL; ZARDAVERINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DRUG REPOSITIONING; DRUG SCREENING; DRUG SPECIFICITY; FEMALE; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; INSULIN RELEASE; MALE; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; ANIMAL; DRUG EFFECTS; PANCREAS; PHYSIOLOGY; REGENERATION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL DIVISION; INSULIN-SECRETING CELLS; MALE; NOREPINEPHRINE; PANCREAS; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION;

EID: 84907679203     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1120     Document Type: Article

References (71)

1. Nichols RJ, New C, Annes JP. Adult tissue sources for new β cells. Transl Res. 2013;163(4):418–431.
2. Green IC, Taylor KW. Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J Endocrinol. 1972;54(2):317–325.
3. Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol. 1978;85(11):818–820.
4. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res. 1997;29(6):301–307.
5. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabet Obes Metab. 2008;10(Suppl 4):32– 42.
6. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care. 2006;29(3):717–718.
7. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic betacells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429(6987):41–46.
8. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest. 2004; 114(7):963–968.
9. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell. 2007;12(5):817–826.
10. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 2008;57(6):1584–1594.
11. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-Cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36(1):111–117.
12. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–990.
13. Steinthorsdottir V, Thorleifsson G, Sulem P, et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. 2014;46(3):294–298.
14. Chick WL, Lauris V, Flewelling JH, Andrews KA, Woodruff JM. Effects of glucose on beta cells in pancreatic monolayer cultures. Endocrinology. 1973;92(1):212–218.
15. Bonner-Weir S, Deery D, Leahy JL, Weir GC. Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes. 1989;38(1):49–53.
16. Porat S, Weinberg-Corem N, Tornovsky-Babaey S, et al. Control of pancreatic β cell regeneration by glucose metabolism. Cell Metab. 2011;13(4):440–449.
17. Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007;38(1–2):193–206.
18. Andersson O, Adams BA, Yoo D, et al. Adenosine signaling promotes regeneration of pancreatic β cells in vivo. Cell Metab. 2012; 15(6):885–894.
19. Wei J, Hanna T, Suda N, Karsenty G, Ducy P. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes. 2014;63(3):1021–1031.
20. Kim JW, Roberts CD, Berg SA, Caicedo A, Roper SD, Chaudhari N. Imaging cyclic AMP changes in pancreatic islets of transgenic reporter mice. PLoS One. 2008;3(5):e2127.
21. Sawada Y, Zhang B, Okajima F, Izumi T, Takeuchi T. PTHrP increases pancreatic beta-cell-specific functions in well-differentiated cells. Mol Cell Endocrinol. 2001;182(2):265–275.
22. Kim MJ, Kang JH, Park YG, et al. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element. J Endocrinol. 2006;188(3):623–633.
23. Shao J, Qiao L, Friedman JE. Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 beta-cells. Am J Physiol. 2004; 286(2):E304–E310.
24. Holz GG 4th, Kühtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon- like peptide-1(7–37). Nature. 1993;361(6410):362–365.
25. Inada A, Hamamoto Y, Tsuura Y, et al. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol. 2004;24(7): 2831–2841.
26. Hennige AM, Burks DJ, Ozcan U, et al. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest. 2003;112(10):1521–1532.
27. Friedrichsen BN, Neubauer N, Lee YC, et al. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol. 2006;188(3):481–492.
28. Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 2003;17(13):1575–1580.
29. Hussain MA, Porras DL, Rowe MH, et al. Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Mol Cell Biol. 2006;26(20):7747–7759.
30. Wicksteed B, Brissova M, Yan W, et al. Conditional gene targeting in mouse pancreatic β-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes. 2010;59(12):3090–3098.
31. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res. 2007;100(3):309–327.
32. Furman B, Pyne N, Flatt P, O’Harte F. Targeting beta-cell cyclic 3β5β adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review. J Pharm Pharmacol. 2004;56(12):1477–1492.
33. Heimann E, Jones HA, Resjo S, Manganiello VC, Stenson L, Degerman E. Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets. PLoS One. 2010; 5(12):e14191.
34. Waddleton D, Wu W, Feng Y, et al. Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol. 2008;76(7):884–893.
35. Rabinovitch A, Blondel B, Murray T, Mintz DH. Cyclic adenosine- 3β,5β-monophosphate stimulates islet B cell replication in neonatal rat pancreatic monolayer cultures. J Clin Invest. 1980;66(5):1065– 1071.
36. Abdollahi M, Chan TS, Subrahmanyam V, O’Brien PJ. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem. 2003;252(1–2):205–211.
37. Xie T, Chen M, Zhang QH, Ma Z, Weinstein LS. Beta cell-specific deficiency of the stimulatoryGprotein alpha-subunit Gsalpha leads to reduced beta cell mass and insulin-deficient diabetes. Proc Natl Acad U S A. 2007;104(49):19601–19606.
38. Fagerholm V, Gronroos T, Marjamaki P, Viljanen T, Scheinin M, Haaparanta M. Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice. Eur J Pharmacol. 2004;505(1–3):243–252.
39. Lacey RJ, Chan SL, Cable HC, et al. Expression of alpha 2- and beta-adrenoceptor subtypes in human islets of Langerhans. J Endocrinol. 1996;148(3):531–543.
40. Regard JB, Kataoka H, Cano DA, et al. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest. 2007;117(12):4034–4043.
41. Rosengren AH, Jokubka R, Tojjar D, et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science. 2010;327(5962):217–220.
42. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–116.
43. Talmud PJ, Cooper JA, Gaunt T, et al. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Diabetologia. 2011;54(7):1710–1719.
44. Gotoh M, Maki T, Satomi S, et al. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation. 1987;43(5): 725–730.
45. Hampel AF. The influence curve and its role in robust estimation. J Am Statist Assoc. 1974;69(346):383.
46. Annes JP, Ryu JH, Lam K, et al. Adenosine kinase inhibition selectively promotes rodent and porcine islet beta-cell replication. Proc Natl Acad U S A. 2012;109(10):3915–3920.
47. Serup P, Petersen HV, Pedersen EE, et al. The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loophelix factor binding site. Biochem J. 1995;310(Pt 3):997–1003.
48. Rieck S, Zhang J, Li Z, et al. Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human islets. Mol Endocrinol. 2012;26(9): 1590–1602.
49. Lee SH, Hao E, Levine F, Itkin-Ansari P. Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells. Islets. 2011;3(6):358–366.
50. Klinger S, Poussin C, Debril MB, Dolci W, Halban PA, Thorens B. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator- alpha and DUSP14. Diabetes. 2008;57(3):584–593.
51. Grauer SM, Pulito VL, Navarra RL, et al. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. J Pharmacol Exp Ther. 2009; 331(2):574–590.
52. Harker LA, Kadatz RA. Mechanism of action of dipyridamole. Thromb Res Suppl. 1983;4:39–46.
53. Dyachok O, Isakov Y, Sågetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature. 2006;439(7074):349–352.
54. Kaihara KA, Dickson LM, Jacobson DA, et al. β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion. Diabetes. 2013;62(5): 1527–1536.
55. Ahrén B. Autonomic regulation of islet hormone secretion–implications for health and disease. Diabetologia. 2000;43(4):393–410.
56. Buse MG, Johnson AH, Kuperminc D, Buse J. Effect of alphaadrenergic blockade on insulin secretion in man. Metab Clin Exp. 1970;19(3):219–225.
57. Peterhoff M, Sieg A, Brede M, Chao CM, Hein L, Ullrich S. Inhibition of insulin secretion via distinct signaling pathways in alpha2- adrenoceptor knockout mice. Eur J Endocrinol. 2003;149(4):343– 350.
58. Ullrich S, Wollheim CB. Expression of both alpha 1- and alpha 2-adrenoceptors in an insulin-secreting cell line. Parallel studies of cytosolic free Ca2+ and insulin release. Mol Pharmacol. 1985; 28(2):100–106.
59. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999;48(12):2270–2276.
60. Gao J, Tian L, Weng G, O’Brien TD, Luo J, Guo Z. Stimulating β-cell replication and improving islet graft function by AR231453, a GPR119 agonist. Transplant Proc. 2011;43(9):3217–3220.
61. Guthalu Kondegowda N, Joshi-Gokhale S, Harb G, et al. Parathyroid hormone-related protein enhances human β-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression. Diabetes. 2010;59(12):3131–3138.
62. Kushner JA, Ciemerych MA, Sicinska E, et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol. 2005;25(9):3752–3762.
63. Zhong L, Georgia S, Tschen SI, Nakayama K, Nakayama K, Bhushan A. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. J Clin Invest. 2007;117(10):2869–2876.
64. Tschen SI, Georgia S, Dhawan S, Bhushan A. Skp2 is required for incretin hormone-mediated β-cell proliferation. Mol Endocrinol. 2011;25(12):2134–2143.
65. Song WJ, Schreiber WE, Zhong E, et al. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes. 2008;57(9):2371– 2381.
66. Furman B, Ong WK, Pyne NJ. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol. 2010;654:281–304.
67. Choi YH, Park S, Hockman S, Zmuda-Trzebiatowska E, et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest. 2006;116(12): 3240–3251.
68. Nawrocki AR, Rodriguez CG, Toolan DM, et al. Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance. Diabetes. 2014;63(1):300–311.
69. Männistö PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51(4):593–628.
70. Avrahami D, Li C, Yu M, Jiao Y, Zhang J, Naji A, Ziaie S, Glaser B, Kaestner KH. Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication. J Clin Invest. 2014;124(2): 670–674.
71. Hennings JM, Ising M, Grautoff S, Himmerich H, Pollmächer T, Schaaf L. Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls. Exp Clin Endocrinol Diabetes. 2010;118(2):98–100.